These results suggest that PD-1 blockade therapy also enhance the immune functions towards various OIs, which highlight the possibility of global restoration of various chronic antigen-specific immune responses even in conditions of massive SIV infection and severe lymphopenia. The gene discussed is PDCD1; the disease is lymphopenia.